Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-09-02A Randomized, Double-blind, Placebo-controlled Trial of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study results posted · 2026-08-13A Randomized Feasibility Clinical Trial of the Management of the Medically-Refractory Motor Symptoms of Advanced Idiopathic Parkinson's Disease With Unilateral Lesioning of the Subthalamic Nucleus Using the ExAblate Transcranial System
-
CLINICAL_TRIALS study results posted · 2026-07-09A Phase IIa Multicenter, Randomized, Double-blind, Placebo-controlled Study Followed by an Open-label Period, to Evaluate the Safety, Tolerability, and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations, Administered With Repeated Subcutaneous ND0612
-
CLINICAL_TRIALS study results posted · 2026-06-24Effects and Mechanisms of Non-invasive Deep Brain Stimulation in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-06-08A Randomized, Controlled, Double-blind, Double-dummy, Multicenter Phase III Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-24Deep Brain Stimulation Surgery for Movement Disorders
-
CLINICAL_TRIALS study record update · 2026-04-24Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
-
CLINICAL_TRIALS study record update · 2026-04-24Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-23Stimulating the Vagus Nerve to Improve Gait in Veterans With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-22Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-21rTMS as a Cognitive Rehabilitation Approach in Veterans With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-21Dose-Escalation, Single-Center, Open-label Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Adeno-associated Virus(AAV) Gene Therapy Product IPS101A in Parkinson's Disease Patients With Hoehn-Yahr Stage 4-5, Diagnosed in More Than 10 Years and Uncontrolled by All Available Monotherapy or Combination Therapy
-
CLINICAL_TRIALS study record update · 2026-04-20Agricultural Health Study: Health Followup
-
CLINICAL_TRIALS study record update · 2026-04-20Deep Brain Stimulation Therapy in Movement Disorders
-
CLINICAL_TRIALS study record update · 2026-04-20A Randomized Feasibility Clinical Trial of the Management of the Medically-Refractory Motor Symptoms of Advanced Idiopathic Parkinson's Disease With Unilateral Lesioning of the Subthalamic Nucleus Using the ExAblate Transcranial System
-
CLINICAL_TRIALS study record update · 2026-04-20A Natural History Study of Treated Parkinson's Disease Patients Experiencing Motor Complications
-
CLINICAL_TRIALS study record update · 2026-04-20Clinical Laboratory Evaluation of Chronic Autonomic Failure
-
CLINICAL_TRIALS study record update · 2026-04-17Developing At-home taVNS for Neurorehabilitation in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-14Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: A Phase I Trial
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase 1 Open-Label Dose Escalation Safety Study of Convection Enhanced Delivery (CED) of Adeno-Associated Virus Encoding Glial Cell Line-Derived Neurotrophic Factor (AAV2-GDNF) in Subjects With Advanced Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-13Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
-
CLINICAL_TRIALS study record update · 2026-04-13Examining Ketamine Effects on Depression, Neuroplasticity, and Inflammation in Veterans With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-13A Single Center, Open, Single Dosing, Dose-escalation, Phase 1/2a Study to Evaluate the Safety and Exploratory Efficacy of Embryonic Stem Cell-derived A9 Dopamine Progenitor Cell (A9-DPC) Therapy in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-13Genotypic Influences on Network Progression in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2026-04-09Vestibulopathy, Imbalance and Gait Disturbances in Parkinson Disease